Changzhou Qianhong Biopharma Co (SZSE:002550) ROCE % : 22.65% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Changzhou Qianhong Biopharma Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 22.65%.

Changzhou Qianhong Biopharma Co ROCE % Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co ROCE % Chart

Changzhou Qianhong Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.00

-7.42

9.58

15.42

8.23

Changzhou Qianhong Biopharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															13.65	-2.32	18.51	14.29	22.65

Changzhou Qianhong Biopharma Co ROCE % Calculation

Changzhou Qianhong Biopharma Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	209.45	/	( ( (2805.938 - 278.219)	+	(2766.081 - 205.811) )	/ 2 )
	=	209.45	/	( (2527.719	+	2560.27)	/ 2 )
	=	209.45	/	2543.9945
	=	8.23 %

Changzhou Qianhong Biopharma Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	569.804	/	( ( (2630.283 - 177.036)	+	(2762.272 - 185.012) )	/ 2 )
	=	569.804	/	( ( 2453.247	+	2577.26 )	/ 2 )
	=	569.804	/	2515.2535
	=	22.65 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Changzhou Qianhong Biopharma Co (SZSE:002550) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Changzhou Qianhong Biopharma Co ROCE % Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Changzhou Qianhong Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022

Website

http://www.qhsh.com.cn

Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Executives

Huang Jie	Executives
Wang Ke	Directors, executives
Jiang Wen Qun	Supervisors
Zou Shao Bo	Executives
Wei Li Jun	Executives
Mei Chun Wei	Executives
Zhou Xiang	Directors, executives
Zhao Gang	Director
Ye Hong Ping	Executives
Liu Jun	Director
Fan Yong	Executives
Jiang Jian Ping	Supervisors
Wang Yao Fang	Director
Hai Tao	Directors, executives
Wang Yi	Director

Changzhou Qianhong Biopharma Co Headlines

No Headlines